Protocolli GOIRC con arruolamento chiuso

GOIRC-08-2018  CABOGEN (osservazionale)

Retrospective analysis of patients with metastatic renal cell carcinoma treated with CABOzantinib: a GENomic signature for describing long-term response – CABOGEN trial

Centro Coordinatore: Reggio Emilia

CABOGEN Valutazione d’impatto privacy

CABOGEN Informativa pazienti non contattabili

GOIRC-01-2020 ALNEO

Phase II, open label, single arm, multicenter study to assess the activity and safety of ALectinib as NE O adjuvant therapy in patients with anaplastic lymphoma kinase positive (ALK+) locally advanced Stage III Non Small Cell Lung Cancer (NSCLC): ALNEO trial-GOIRC-01-2020

Centro Coordinatore: Parma

GOIRC-05-2020 DUPLE

A multicentre phase II, single arm study of Durvalumab (MEDI 4736) with Carboplatin plus Etoposide for 4 cycles followed by Durvalumab maintenance in patients with metastatic pulmonary large-cell neuroendocrine carcinoma (LCNEC) – DUPLE trial

Centro Coordinatore: Bologna